Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Marchewski (Rostock, Germany), K. Bratke (Rostock, Germany), G. Schwefel (Rostock, Germany), J. Virchow (Rostock, Germany), M. Lommatzsch (Rostock, Germany). Late Breaking Abstract - Benralizumab treatment strongly reduces blood basophils in patients with severe eosinophilic asthma. 529

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Late Breaking Abstract - The blood eosinophils count as a predictor of the response for omalizumab (OMA) in patients suffering from severe allergic asthma Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma. Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Late Breaking Abstract - Mepolizumab reduces exacerbations in eosinophilic COPD Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Late Breaking Abstract - A GATA3-specific DNAzyme attenuates sputum eosinophilia in COPD patients with eosinophilic airway inflammation Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Late Breaking Abstract - Daily physical activity in patients with severe eosinophilic asthma and the effect of anti-IL5 therapy. Source: International Congress 2018 – New pharmacological strategies in airway diseases Year: 2018 Late Breaking Abstract - Early response to benralizumab in Canadians with severe eosinophilic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD. Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Late Breaking Abstract - Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021 Late Breaking Abstract - Association between blood eosinophils and exacerbation risk in COPD primary care Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Late Breaking Abstract - Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - Effect of timapiprant, a DP2 antagonist, on airway inflammation in severe eosinophilic asthma Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma Year: 2019 LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 Treatment of moderate-severe asthma with omalizumab is associated with a decrease in peripheral blood eosinophils Source: Eur Respir J 2007; 30: Suppl. 51, 353s Year: 2007 Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis Source: International Congress 2015 – Epidemiological studies of asthma and allergy Year: 2015 Late Breaking Abstract - Blood eosinophil count and exacerbation history in COPD: pooled analysis of 24,103 patients Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Are acute exacerbation blood eosinophil numbers associated with clinical pattern of preschool wheeze? Source: International Congress 2015 – More paediatric asthma and allergy Year: 2015